Integrative Study of Physiological Changes Induced by a 5-Day Dry Immersion on 20 Healthy Female Volunteers (DI5-Women)

  • STATUS
    Recruiting
  • participants needed
    20
  • sponsor
    Centre National d'Etudes Spatiales
Updated on 16 September 2021
Accepts healthy volunteers

Summary

Dry immersion (DI) is a ground-based model of prolonged conditions of simulated microgravity. Dry immersion involves immersing the subject in water covered with an elastic waterproof fabric. As a result, the immersed subject, who is freely suspended in the water mass, remains dry. Within a relatively short duration, the model can faithfully reproduce most physiological effects of actual microgravity, including centralization of body fluids, support unloading, and hypokinesia.
The objective of the study is to evaluate the physiological changes induced by 5 days of dry immersion in the female organism. The main physiological systems will be explored before, during and after the 5 days of immersion through a battery of specific tests and measurements. The results will be analyzed by scientists specializing in each field in order to better understand the dry immersion model, to compare its effects with those of the bedrest model and those of spaceflight. The clinical (adverse effects, comfort of subjects) and operational aspects are also part of the secondary objectives of the study.

Description

The space agencies are actively engaged in studying the physiological adaptation to space environment through studies on board the International Space Station (ISS) but also on the ground. Ground-based experiments simulating the effects of weightlessness are used to better understand the mechanisms of physiological adaptation, design and validate the countermeasures. Dry immersion (DI) is a ground-based model of prolonged conditions of simulated microgravity, which has been mainly used in Russia. The past years however, the model has been implemented as well in Europe and expertise in conducting DI studies has been gained in particular in France where a few DI studies have been conducted in the MEDES Space Clinic in Toulouse for CNES (French Space Agency). Dry immersion involves immersing the subject in water covered with an elastic waterproof fabric. As a result, the immersed subject, who is freely suspended in the water mass, remains dry. Within a relatively short duration, the model can faithfully reproduce most physiological effects of actual microgravity, including centralization of body fluids, support unloading, and hypokinesia. Furthermore, physiological changes have been reported in the neuromuscular, skeletal and sensorimotor systems, in fluid electrolyte regulation, in the cardiovascular system, metabolism, blood and immunity, respiration, and thermoregulation. Dry immersion provides a unique opportunity to study the physiological effects of the lack of a supporting structure for the body (a phenomenon called 'supportlessness'). As such, dry immersion is proposed to mimic actual spaceflight in terms of the monotonous environment, posture-motion limitations, hemodynamic changes and hypokinetic effects, support unloading, and decreased proprioceptive input. Immersion studies have so far only been conducted in men and a minority of studies using the bedrest model have included women. Likewise, few studies conducted to date have investigated gender differences in the astronaut population. The small number of female astronauts may be part of the reason why scientific data are lacking to draw valid conclusions about possible gender differences. However, if women currently constitute only about 10% of astronauts, women are and will be more and more represented in crews. Women now constitute 30% of American crews and NASA (US space agency) has announced gender parity for crews on future lunar missions. It is therefore essential to study the physiological changes induced by weightlessness in women, to compare them with those observed in men and to develop efficient countermeasures for preventing them. The main physiological systems will be explored before, during and after the 5 days of immersion through a battery of specific standardized tests and measurements. The objective of the study is to evaluate the physiological changes induced by 5 days of dry immersion in the female organism. The study conditions such as patient recruitment, nutrition, data collection, data management, reporting for adverse events are standardized. The results will be analyzed by scientists specializing in each field in order to better understand the dry immersion model, to compare its effects with those of the bedrest model and those of spaceflight. The clinical (adverse effects, comfort of subjects) and operational aspects are also part of the secondary objectives of the study.
Twenty healthy female subjects will participate in the study. There is no published data on dry immersion with female participation to help calculation the sample size. Moreover, female spaceflight and bedrest data are scarce, and do not provide any insight into inter-individual variability. This prolonged DI protocol in women is conceived as a pilot, descriptive, explorative study, as well as an operational and methodological study. Power-based calculation of the number of subjects is not directly applicable for such explorative studies. However, based on effect sizes obtained with previous DI studies in men, a total of 20 subjects was deemed necessary for this study.

Details
Condition Weightlessness, Weightlessness; Adverse Effect
Age 20years - 40years
Treatment Dry immersion
Clinical Study IdentifierNCT05043974
SponsorCentre National d'Etudes Spatiales
Last Modified on16 September 2021

Eligibility

Yes No Not Sure

Inclusion Criteria

Healthy female volunteer (see below the description of medical tests and laboratory analysis performed at the selection visit)
Age 20 to 40
No overweight nor excessive thinness with BMI (weight Kg/ height m2) between 20 and 26
Height between 158cm and 180 cm
Regular menstrual cycles and cycles lasting between 20 and 35 days
Without oestroprogestative contraception (i.e., oral progestative contraception, IUDs, implants or absence of contraception are allowed)
Certified as healthy by a comprehensive clinical assessment (detailed medical history and complete physical examination): in particular, free from any chronic disease or any acute infectious disease or cardiovascular, neurological, ENT (especially orthostatic hypotension and vestibular disorders), orthopaedic or musculoskeletal disorders
Fitness level assessment
if age < 35 years: 35 ml/min./kg < VO2max < 55 ml/min./kg
if age > 35 years: 30 ml/min./kg < VO2max < 55 ml/min./kg
Non active smokers
No alcohol, or drug addiction, and no medical treatment (with the exception of the aforementioned accepted means of contraception)
Covered by a Health Insurance System
Having signed the informed consent
Free from any engagement during the study

Exclusion Criteria

Any history or presence of clinically relevant cardiovascular, neurological or ENT (especially orthostatic hypotension and vestibular disorders), any chronic disease; any acute infectious disease, in particular
Symptomatic orthostatic hypotension whatever the decrease in blood pressure
Asymptomatic postural hypotension defined by a decrease in SBP equal to or greater than 20 mmHg within 3 minutes when changing from the supine to the standing position
Cardiac rhythm disorders
Hypertension
Chronic back pains
Vertebral fracture, scoliosis or herniated disc
Glaucoma
Self-reported hearing problems
History of migraines
History of hiatus hernia or gastro-esophageal reflux
History of thyroid dysfunction, renal stones, diabetes
History of head trauma
Abnormal result for lower limbs echo-doppler
History of genetic muscle and bone diseases of any kind
Past records of thrombophlebitis, family history of thrombosis or positive response in thrombosis screening procedure (anti thrombin III, S-protein, C-protein, factor V Leiden mutation and the mutation 20210 of the prothrombin gene)
Women who have stopped breastfeeding within 2 months before the start of the study
Women who have undergone an abortion within 3 months before the start of the study
Irregular menstrual cycles or cycles lasting less than 20 days or more than 35 days
Oestroprogestative contraception
Recent implementation or change in hormonal contraceptive (in the last 6 months)
Bone mineral density: T-score -1.5
Poor tolerance to blood sampling
Having given whole blood (more than 8ml/kg) in a period of 8 weeks or less before the start of the experiment, or having given whole blood more than 3 times in the past year
Significant history of allergy, especially no dermatological allergy
History of food allergy
Significant anomaly detected in the biological analysis
Positive reaction to any of the following tests: HVA IgM (hepatitis A), HBs antigen (hepatitis B), anti-HVC antibodies (hepatitis C), anti-HIV1+2 antibodies
Vegetarian or vegan
Refusal to give permission to contact her general practitioner
Subject who, in the judgment of the investigator, is likely to be non-compliant during the study, or unable to cooperate because of a language problem or poor mental development
Subject already participating or in the exclusion period of a clinical research
Subject who has received more than 4500 Euros within 12 months for being a research subject
Subject who cannot be contacted in case of emergency
MRI contraindications
History or active claustrophobia
Osteosynthesis material, presence of metallic implants or any other contra-indication for MRI
Allergy to Gadolinium
Vulnerable persons according to law "Code de la Sant Publique" (L1121-5 to
L1121-8)
Pregnant women (urine pregnancy test performed at the selection visit and on the day of arrival in the facility)
Women during childbirth and breastfeeding mothers
Persons deprived of their liberty by an administrative or judicial decision
Persons under involuntary psychiatric care
Persons admitted in a health or social establishment for purposes other than research
Minors
Adults subject to legal protection (subject under guardianship or trusteeship) or unable to express their consent
Clear my responses

How to participate?

Step 1 Connect with a study center
Message sent successfully.
We have submitted the information you provided to the research team at the location you chose. For your records, we have sent a copy of the message to your email address.
If you would like to be informed of other studies that may be of interest to you, you may sign up for Patient Notification Service.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Other language

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Loading...

Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.